Hsing‐I Ho

Merck & Co., Inc., Rahway, NJ, USA (United States)

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Programmable CRISPR‐Cas transcriptional activation in bacteria”.

Programmable CRISPR‐Cas transcriptional activation in bacteria

Molecular Systems Biology(2020)10.15252/msb.20199427

N/A

0DataRank · unranked

91 citations

Jennifer R. Fang, Jacky Cheung, Harris H. Wang, Hsing‐I Ho

Programmable and portable CRISPR-Cas transcriptional activation in bacteria

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.03.882431

N/A

0DataRank · unranked

7 citations

Jennifer Fang, Jacky Cheung, Harris H. Wang, Hsing‐I Ho

Transcriptional milestones in Dictyostelium development

Genome Research(2021)10.1101/gr.275496.121

N/A

0DataRank · unranked

33 citations

Karin Hrovatin, Shigenori Hirose, Amanda Nicole Webb, Hsing‐I Ho, Blaž Zupan +2 more

Transcriptional milestones in Dictyostelium development

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.27.445976

N/A

0DataRank · unranked

1 citations

Karin Hrovatin, Shigenori Hirose, Amanda Nicole Webb, Hsing‐I Ho, Blaž Zupan +2 more